Skip to Content

ST Changyao Under Investigation by China's Securities Regulator for Alleged Financial Misreporting

The event highlights regulatory scrutiny over corporate financial practices, with potential severe...
Key Metrics

10.52

Heat Index
  • Impact Level
    Medium
  • Scope Level
    National
  • Last Update
    2025-12-03
Key Impacts
Negative Impacts (6)
ST长药
"ST"-labelled A-share Stocks
Chinese Small-cap Pharmaceutical Equities
CSI Smallcap Index
Audit & Accounting Service Firms in China
Large-cap Chinese Pharmaceutical Equities
Total impacts: 6 | Positive: 0 | Negative: 6
Event Overview

The event highlights regulatory scrutiny over corporate financial practices, with potential severe consequences such as delisting. It underscores the importance of transparency and accountability in financial reporting.

Collect Records
ST长药因涉嫌财务数据虚假记载被中国证监会立案调查
2025-12-03 18:20

ST长药于2025年11月7日收到中国证监会的《立案告知书》，因涉嫌财务数据虚假记载被立案调查。若最终认定的事实触及重大违法强制退市情形，公司股票将被强制退市。

Total records: 1
Pentagon Invests $1 Billion in Low-Cost, Disposable Attack Drones
The initiative underscores a strategic shift towards cost-effective, high-volume drone warfare.